Detection of complex genetic alterations in human glioblastoma multiforme using comparative genomic hybridization

Journal of Neuropathology and Experimental Neurology

Volumn 55, Issue 1, 1996, Pages 81-87

  Schlegel, Jürgen ^a,d   Scherthan, Harry ^b   Arens, Norbert ^b   Stumm, Gabi ^a   Kiessling, Marika ^c  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Universität Kaiserslautern ^*  (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Cell cycle; Cytogenetics; Epidermal growth factor receptor; Glioblastoma multiforme

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 10; CHROMOSOME 12Q; CHROMOSOME 19; CHROMOSOME 7; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME LOSS; GENETIC LINKAGE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING;

EID: 0030020246     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199601000-00008     Document Type: Article

References (44)

1. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990:61:759-67
2. Venter DJ, Thomas DGT. Multiple sequential molecular abnormalities in the evolution of human gliomas. Br J Cancer 1991;63:753-57
3. Wong AJ, Zoltick PW, Moscatello DK. The molecular biology and molecular genetics of astrocytic neoplasms. Semin Oncol 1994,21: 139-48
4. Lang FF, Miller DC, Koslow M, Newcomb EW. Pathways leading to glioblastoma multiforme: A molecular analysis of genetic alterations in 65 astrocytic tumors. J Neurosurg 1994;81:427-36
5. Fuller GN, Bigner SH. Amplified cellular oncogenes in neoplasms of the human central nervous system. Mutat Res 1992;276:299-306
6. Leenstra S, Bijlsma EK, Troost D, et al. Allele loss on chromosomes 10 and 17p and epidermal growth factor receptor gene amplification in human malignant astrocytoma related to prognosis. Br J Cancer 1994;70:684-89
7. Schlegel J, Merdes A, Stumm G, et al. Amplification of the epidermal growth factor receptor gene correlates with different growth behaviour in human glioblastoma. Int J Cancer 1994;56:72-77
8. James CD, Carlbom E, Dumanski J, et al. Clonal genomic alterations in glioma malignancy stages. Cancer Res 1988;48:5546-51
9. von Deimling A, Louis DN, von Ammon K, et al. Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J Neurosurg 1992;77:295-301
10. Frankel RH, Bayona W, Koslow M, Newcomb EW. p53 Mutations in human malignant gliomas: Comparison of loss of heterozygosity with mutation frequency. Cancer Res 1992;52:1427-33
11. Rasheed BKA, McLendon RE, Herndon JE, et al. Alterations of the TP53 gene in human gliomas. Cancer Res 1994;54:1324-30
12. Chozick BS, Weicker ME, Pezzullo JC, et al. Pattern of mutant p53 expression in human astrocytomas suggests the existence of alternate pathways of tumorigenesis. Cancer 1994;73.406-15
13. Kallioniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992;258:818-21
14. du Manoir S, Speicher MR, Joos S, et al. Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet 1993;90:590-610
15. Kleihues P, Burger PC, Scheithauer BW. eds. Histological typing of tumors of the central nervous system. International histological classification of tumors, 2nd ed. Geneva: WHO, 1993
16. Sambrook J, Frisch EF, Maniatis T. Molecular cloning. A laboratory manual, 2nd ed. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1989
17. Scherthan H, Cremer T Methodology of non-isotopic in situ-hybridization in embedded tissue sections. In: Adolph KW, ed. Methods in molecular genetics, vol. 5. San Diego: Academic Press, 1994:223-38
18. Ullrich A, Coussens L, Hayflick JS, et al. Human epidermal growth factor receptor cDNA sequence and abberant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 1984;309: 418-25
19. Schlegel J, Bocker T, Zirngibl H, Hofstädter F, Rüschoff J. Detection of microsatellite instability in human colorectal carcinomas using a non-radioactive PCR-based screening technique. Virchows Arch 1995;426:223-27
20. Louis DN, von Deimling A, Seizinger BR. A (CA)n dinucleotide repeat assay for evaluating loss of allelic heterozygosity in small and archival human brain tumor specimens. Am J Pathol 1992;141: 777-82
21. Ichimura K, Schmidt EE, Yamaguchi N, James CD, Collins VP A common region of homozygous deletion in malignant human gliomas lies between the IFN alpha/omega gene cluster and the D9S171 locus. Cancer Res 1994;54:3127-30
22. Budowle B, Chakraborty R, Giusti AM, Eisenberg AJ, Allen RC. Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE. Am J Hum Genet 1991,48:137-44
23. James CD, Collins VP. Molecular genetic characterization of CNS tumor oncogenesis. Adv Cancer Res 1992;58:121-42
24. Joos S, Scherthan H, Speicher MR, Schlegel J, Cremer T, Lichter P. Detection of amplified genomic sequences by reverse chromosome painting using genomic tumor DNA as probe. Hum Genet 1993;90:584-89
25. Sehröck E, Thiel G, Lozanova T, et al. Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and non-random chromosomal gains and losses. Am J Pathol 1994;144:1203-18
26. Thiel G, Losanowa T, Kintzel D, et al. Karyotypes in 90 human gliomas. Cancer Genet Cytogenet 1992;58:109-20
27. von Deimling A, Bender B, Jahnke R, et al. Loci associated with malignant progression in astrocytomas: A candidate on chromosome #19q. Cancer Res 1994;54:1397-1401
28. VandenBerg SR. Current diagnostic concepts of astrocytic tumors. J Neuropathol Exp Neurol 1992;51:644-57
29. Newcomb EW, Madonia WJ, Pisharody S, Lang FF, Koslow M, Miller DC. A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme. Brain Pathol 1993;3: 229-36
30. Fischer U, Wullich B, Sattler HP, Götten E, Zang KD, Meese E. DNA amplifications on chromosome 7, 9 and 12 in glioblastoma detected by reverse chromosome painting. Eur J Cancer 1994;30: 1124-27
31. Bigner SH, Humphrey PA, Wong AJ, et al. Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts. Cancer Res 1990;50:8017-22
32. Reifenberger G, Reifenberger J, Ichimura K, Meltzer PS, Collins VP. Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: Preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Res 1994;54:4299-4303
33. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993;366.704-7
34. Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994;264:436-40
35. Dreyling MH, Bohlander SK, Adeyanju MO, Olopade OI. Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization. Cancer Res 1995;55:984-88
36. Nishikawa R, Furnari FB. Lin H, et al. Loss of p16INK4 expression is frequent in high grade gliomas. Cancer Res 1995;55:1941-45
37. Walker DG, Duan W, Popovic EA, Kaye AH, Tomlinson FH, Lavin M. Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas. Cancer Res 1995;55:20-23
38. Giani C, Finocchiaro G. Mutation rate of the CDKN2 gene in malignant gliomas. Cancer Res 1994;54:6338-39
39. Jen J, Harper JW, Bigner SH, et al. Deletion of p16 and p15 genes in brain tumors. Cancer Res 1994;54:6353-58
40. Arap W, Nishikawa R, Furnari FB, Cavenee WK, Huang HJ. Replacement of the p16/CDKN2 gene suppresses human glioma cell growth. Cancer Res 1995;55:1351-54
41. Hunter T, Pines J. Cyclins and cancer II: Cyclin D and CDK inhibitors come to age. Cell 1994;79:573-82
42. Henson JW, Schnitker BL, Correa KM, et al. The retinoblastoma gene is involved in malignant progression of astrocytomas Ann Neurol 1994;36:714-21
43. He J, Allen JR, Collins VP, et al. CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines. Cancer Res 1994;54:5804-7
44. Schmidt EE, Ichimura K, Reifenberger G, Collins VP. CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res 1994;54:6321-24